Clinical Trial Update: Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Akeso reports that the Phase 2 clinical study of AK101 in moderate to severe plaque psoriasis has completed. The summary does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AK101

Snippet

Sponsor: Akeso | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED